PA
JMIA

PharVision Advisers’s Jumia Technologies JMIA Stock Holding History

PharVision Advisers’s Portfolio JMIA Stock Details JMIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85.9K Sell
12,454
-14,780
-54% -$149K 0.87% 59
2025
Q4 		$340K Buy
+27,234
New +$315K 0.17% 208

Other funds holding JMIA

F1I
Fund 1 Investments Rincon, Puerto Rico $872M AUM 50.95% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
GEH
General Equity Holdings Brooklyn, New York $135M AUM 32.96% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PharVision Advisers's JMIA Position: Q1 2026 in Review

PharVision Advisers reduced its Jumia Technologies (JMIA) stake by 54% in Q1 2026, selling an estimated $149K and leaving 12,454 shares worth $85.9K. The position accounts for 0.87% of the portfolio, ranked #59.

PharVision Advisers first reported a position in JMIA in Q4 2025 and has held it in 2 quarters since. The position peaked at $340K in Q4 2025. 148 funds tracked by Wall St. Rank hold JMIA as of Q1 2026.

  • PharVision Advisers held 12,454 shares of Jumia Technologies worth $85.9K as of Q1 2026.
  • PharVision Advisers sold 14,780 Jumia Technologies shares in Q1 2026, an estimated $149K.
  • Jumia Technologies made up 0.87% of PharVision Advisers's portfolio in Q1 2026, its #59 holding.
  • PharVision Advisers first reported a position in Jumia Technologies in Q4 2025 and has held it in 2 quarters since.
  • PharVision Advisers's Jumia Technologies position peaked at $340K in Q4 2025.
  • 148 funds tracked by Wall St. Rank held Jumia Technologies as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.